1. Home
  2. KDK vs MYGN Comparison

KDK vs MYGN Comparison

Compare KDK & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kodiak AI Inc.

KDK

Kodiak AI Inc.

N/A

Current Price

$1.30

Market Cap

335.0M

Sector

Technology

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$6.08

Market Cap

372.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KDK
MYGN
Founded
2018
1991
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
372.1M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
KDK
MYGN
Price
$1.30
$6.08
Analyst Decision
Strong Buy
Hold
Analyst Count
9
9
Target Price
★ $9.67
$4.49
AVG Volume (30 Days)
★ 5.8M
2.9M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
$3,797,000.00
★ $771,400,000.00
Revenue This Year
$181.17
N/A
Revenue Next Year
$208.63
$5.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$0.96
$2.74
52 Week High
$11.35
$8.09

Technical Indicators

Market Signals
Indicator
KDK
MYGN
Relative Strength Index (RSI) 41.64 61.46
Support Level $0.96 $4.15
Resistance Level $1.43 $6.49
Average True Range (ATR) 0.13 0.42
MACD 0.07 -0.01
Stochastic Oscillator 71.87 53.29

Price Performance

Historical Comparison
KDK
MYGN

About KDK Kodiak AI Inc.

Kodiak AI Inc is a provider of artificial intelligence (AI)-powered autonomous vehicle technology. This technology addresses the needs of the long-haul trucking, industrial trucking, and defense industries. The company's core offering, the Kodiak Driver, is a single-platform virtual driver that combines advanced AI software with modular hardware for customer deployments. All company operations are conducted in the United States. The company has one operating and reportable segment related to the development of autonomous vehicle technology and related services that can be applied at scale across a broad range of industries and environments.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: